ARCHIVES

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

This article is from The Cancer Letter archive.

Vol. 23 No. 20 | May 23, 1997

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986